| RS1195820653 |
PDZD7
|
Health Risk |
Likely pathogenic |
— |
| RS1195825877 |
CEP120
|
Health Risk |
Likely pathogenic |
— |
| RS1195831432 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1195840845 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Inborn genetic diseases |
| RS1195873978 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1195882977 |
PDE6C
|
Health Risk |
Pathogenic |
— |
| RS1195885907 |
OAT
|
Health Risk |
Pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS1195908031 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS1195908562 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS1195919156 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1195935577 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Vesicoureteral reflux 8, Cardiovascular phenotype |
| RS1195974666 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1196000654 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1196005021 |
SMAD6
|
Health Risk |
Pathogenic/Likely pathogenic |
Aortic valve disease 2, Radioulnar synostosis |
| RS1196005889 |
ATR
|
Health Risk |
Pathogenic/Likely pathogenic |
Seckel syndrome 1, Seckel syndrome 1 |
| RS1196012985 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Zellweger spectrum disorders, Peroxisome biogenesis disorder |
| RS1196026821 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1196046487 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS1196057129 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1196091318 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Progressive familial heart block type IB |
| RS1196117849 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS1196142320 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1196145112 |
ELANE
|
Health Risk |
Conflicting classifications of pathogenicity |
Cyclical neutropenia, Neutropenia |
| RS1196153507 |
MAK
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 62 |
| RS1196160200 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS1196161699 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1196190757 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS1196215011 |
SYCP2L
|
Health Risk |
Pathogenic |
Premature ovarian failure 24, Premature ovarian failure 24 |
| RS1196218767 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4C |
| RS1196223064 |
CNTN2
|
Health Risk |
Likely pathogenic |
Epilepsy, familial adult myoclonic |
| RS1196239075 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome 1, Lynch syndrome 1 |
| RS1196276711 |
TUBGCP4
|
Health Risk |
Likely pathogenic |
Microcephaly and chorioretinopathy 3, Microcephaly and chorioretinopathy 3 |
| RS1196278287 |
GJC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 2, Spastic paraplegia |
| RS1196281944 |
TCTN2
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1196290590 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS1196317554 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS1196325597 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1196342305 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1196356920 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Intrauterine growth retardation, metaphyseal dysplasia |
| RS1196360635 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1196380787 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1196401015 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy 1, Glycine encephalopathy 1 |
| RS1196406851 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1196443543 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1196469674 |
ZMIZ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Malignant tumor of urinary bladder |
| RS1196489060 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa |
| RS1196495584 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS1196497635 |
SGPL1
|
Health Risk |
Pathogenic |
— |
| RS1196510455 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1196530552 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1196551352 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1196551559 |
RFX5
|
Health Risk |
Pathogenic/Likely pathogenic |
MHC class II deficiency, MHC class II deficiency 5 |
| RS1196559591 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1196587621 |
LPIN2
|
Health Risk |
Likely pathogenic |
Majeed syndrome, Majeed syndrome |
| RS1196609413 |
LMOD1
|
Health Risk |
Pathogenic |
Megacystis-microcolon-intestinal hypoperistalsis syndrome 3, Megacystis-microcolon-intestinal hypoperistalsis syndrome 3 |
| RS1196611507 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1196636083 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1196655928 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS1196657001 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS1196701463 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
TP63-Related Spectrum Disorders, 8 conditions |
| RS1196710568 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1196710763 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1196801124 |
PCARE
|
Health Risk |
Pathogenic |
Retinal dystrophy, PCARE-related disorder |
| RS1196814221 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1196820381 |
COL4A5
|
Health Risk |
Likely pathogenic |
Steroid-resistant nephrotic syndrome, Steroid-resistant nephrotic syndrome |
| RS1196822993 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1196823355 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Primrose syndrome, Primrose syndrome |
| RS1196835948 |
HSPG2
|
Health Risk |
Likely pathogenic |
Lethal Kniest-like syndrome, Lethal Kniest-like syndrome |
| RS1196877210 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1196886096 |
CEP78
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy and hearing loss 1 |
| RS1196891209 |
POLR3A
|
Health Risk |
Likely pathogenic |
POLR3A-related neurological disorders, POLR3A-related neurological disorders |
| RS1196903858 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1196915574 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1196929384 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1196937077 |
CSF2RA
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS1196938557 |
CEP290
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1196949061 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1196950486 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1196957609 |
LCA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1196959150 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Classic or attenuated familial adenomatous polyposis |
| RS1196972648 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1196976671 |
ALPL
|
Health Risk |
Likely pathogenic |
Adult hypophosphatasia, Hypophosphatasia |
| RS1196979432 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1196984337 |
RFXANK
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency 2 |
| RS1196996393 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Alport syndrome |
| RS1197018531 |
SKIC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1197039101 |
CLTC
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1197046699 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1197071459 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1197097532 |
ASNS
|
Health Risk |
Pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS1197104410 |
SZT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1197105310 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1197109885 |
TMEM231
|
Health Risk |
Pathogenic |
Joubert syndrome 20, Meckel syndrome |
| RS1197125822 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1197126131 |
IMPG2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 56, Retinitis pigmentosa 56 |
| RS1197127947 |
TCIRG1
|
Health Risk |
Likely pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1197133430 |
ACADVL
|
Health Risk |
Pathogenic/Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1197141604 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1197184207 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1197184303 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |